Skip to main content

Table 2 Inclusion and exclusion criteria of the DISTINCT Study

From: Rationale, design, and methods of electroencephalography-based investigation of the effects of oral desmopressin on improving slow-wave sleep time in nocturnal polyuria patients (the DISTINCT study): protocol for a single-arm, open-label, single-assignment trial

Inclusion criteria

Exclusion criteria

1. Nocturnal urinary frequency is 2 or more.

1. Concentration of serum sodium is less than 135 mEq/L

2. Nocturnal polyuria index is 0.33 or more.

2. Habitual or psychogenic polydipsia

3. FUSP is 2.5 h or less.

3. Heart failure, the history of heart failure, or suspected heart failure

4. Concentration of serum sodium is 135 mEq/L or more.

4. Fluid retention that requires diuretic treatment, whether currently or in the patient’s medical history

5. Creatinine clearance or eGFR is 50 mL/min/1.73m2 or more.

5. Antidiuretic hormone incompatible secretion syndrome

6. Patients with BPH or OAB are acceptable if the storage symptoms (urgency and daytime frequency) are well managed and stable for 3 months or more by any treatments or 6 months or more by 5-alpha reductase inhibitors.

6. Moderate or severe renal failure (Creatinine clearance or eGFR < 50 mL/min/1.73m2)

7. Hypersensitivity to desmopressin or the history, whether currently or in the patient’s medical history

8. Concomitant or scheduled administration of thiazides, thiazide-like diuretics, or loop diuretics

9. Concomitant or scheduled administration of corticosteroids

10. Cardiac pacemaker implantation

11. Judged to be inappropriate by the principal investigator or subinvestigators

  1. FUSP the first uninterrupted sleep period, BPH benign prostatic hyperplasia, OAB overactive bladder, eGFR estimate glomerular filtration rate